Identification of novel inhibitor of enoyl-acyl carrier protein reductase (inha) enzyme in mycobacterium tuberculosis from plant-derived metabolites: an in silico study

HIGHLIGHTS

  • who: Kratika Singh and colleagues from the Department of Biosciences, Integral University, IIRC-3, Kursi Road, Lucknow, Uttar Pradesh, India have published the Article: Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in Mycobacterium tuberculosis from Plant-Derived Metabolites: An In Silico Study, in the Journal: Antibiotics 2022, 1038 of 12/Oct/2021
  • what: This study shows that the identified natural compound gravacridonediol possesses drug-like properties and also holds promise in inhibiting InhA a key target enzyme of M.tb. In the present study, InhA inhibitors from the bioactive compounds . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?